ReposiTrak (NYSE:TRAK) CEO Sells $43,678.05 in Stock

Key Points

• CEO Randall Fields sold 2,535 shares of ReposiTrak at an average price of $17.23, totaling $43,678.05, resulting in a 3.40% decrease in his holdings.
• ReposiTrak recently cut its dividend, announcing a $0.0182 quarterly dividend, which reflects an annual yield of 0.4%.
• The company has seen significant institutional investment, with Ashford Capital Management increasing its stake by 93.7%, now owning 792,154 shares valued at approximately $15.57 million.

ReposiTrak Inc. (NYSE:TRAK - Get Free Report) CEO Randall Fields sold 2,535 shares of the business's stock in a transaction that occurred on Wednesday, September 17th. The stock was sold at an average price of $17.23, for a total transaction of $43,678.05. Following the sale, the chief executive officer directly owned 72,000 shares in the company, valued at approximately $1,240,560. This represents a 3.40% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.

ReposiTrak Trading Up 1.1%

NYSE TRAK traded up $0.19 on Wednesday, hitting $17.17. 44,544 shares of the company's stock traded hands, compared to its average volume of 50,532. The company has a quick ratio of 6.03, a current ratio of 6.03 and a debt-to-equity ratio of 0.01. ReposiTrak Inc. has a 1-year low of $15.12 and a 1-year high of $25.01. The stock's 50-day moving average price is $17.17. The firm has a market cap of $313.87 million, a price-to-earnings ratio of 50.50 and a beta of 0.47.

ReposiTrak Cuts Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, August 14th. Investors of record on Monday, June 30th were paid a $0.0182 dividend. This represents a $0.07 annualized dividend and a dividend yield of 0.4%. The ex-dividend date was Monday, June 30th. ReposiTrak's payout ratio is currently 20.59%.

Institutional Investors Weigh In On ReposiTrak

Several hedge funds and other institutional investors have recently bought and sold shares of TRAK. Ashford Capital Management Inc. boosted its stake in ReposiTrak by 93.7% during the second quarter. Ashford Capital Management Inc. now owns 792,154 shares of the company's stock worth $15,566,000 after buying an additional 383,283 shares during the period. Handelsbanken Fonder AB boosted its stake in shares of ReposiTrak by 7.1% in the second quarter. Handelsbanken Fonder AB now owns 1,654,348 shares of the company's stock valued at $32,508,000 after purchasing an additional 110,000 shares during the period. Los Angeles Capital Management LLC purchased a new position in shares of ReposiTrak in the second quarter valued at approximately $818,000. Jane Street Group LLC purchased a new position in ReposiTrak in the second quarter worth approximately $802,000. Finally, Coldstream Capital Management Inc. raised its holdings in ReposiTrak by 47,619.0% during the second quarter. Coldstream Capital Management Inc. now owns 20,042 shares of the company's stock worth $394,000 after purchasing an additional 20,000 shares in the last quarter. 27.35% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, Wall Street Zen upgraded shares of ReposiTrak from a "hold" rating to a "buy" rating in a research note on Thursday, May 22nd.

ReposiTrak Company Profile

Park City Group, Inc, a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.